학술논문
A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study
Document Type
Article
Author
Source
In Journal of Thoracic Oncology January 2022 17(1):130-140
Subject
Language
ISSN
1556-0864